XIAP gene therapy (Neurologix)

N/A

Report date: 2023/10/26 17:03:00

Base Information

Drug NameXIAP gene therapy (Neurologix)

Drug Alias Namerecombinant adeno-associated virus encoded gene for X-linked mammalian inhibitor of apoptosis protein (XIAP)

ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector

Mechanisms of ActionInhibitor of apoptosis protein 3 gene transference

TargetsInhibitor of apoptosis protein 3

Therapy Area/IndicationsHuntington Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesNeurologix Inc

China Registration ClassN/A

Active CompaniesNeurologix Inc

Inactive CompaniesN/A

Active IndicationsHuntington Disease

Inactive IndicationsN/A

ATC CodeN/A